Patents Assigned to OPPILAN PHARMA LIMITED
  • Crystalline forms of an S1P receptor modulator
    Patent number: 12612401
    Abstract: Described herein are crystalline forms of (R)-5-(2,5-dichloro-4-(5-(8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl)-1,2,4-oxadiazol-3-yl)phenoxy)piperidin-2-one, or a salt or solvate thereof.
    Type: Grant
    Filed: July 5, 2023
    Date of Patent: April 28, 2026
    Assignee: OPPILAN PHARMA LIMITED
    Inventors: John Nuss, Jason Harris, Shendong Yuan, Scott Alan Wolckenhauer